Dare Bioscience
DARE
14 hedge funds and large institutions have $725K invested in Dare Bioscience in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
16% more capital invested
Capital invested by funds: $624K → $725K (+$101K)
0.03% less ownership
Funds ownership: 0.4% → 0.37% (-0.03%)
13% less funds holding
Funds holding: 16 → 14 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IVM
InterWest Venture Management
San Francisco,
California
|
+$40.9K |
| 2 |
VF
Virtu Financial
New York
|
+$40.6K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$7.3K |
| 4 |
Renaissance Technologies
New York
|
+$4.26K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$311 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFS
Founders Financial Securities
Towson,
Maryland
|
-$16K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$886 |
DARE Hedge Fund Activity: Q4 2019 in Review
14 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2019, worth a combined $725K — up 16% from $624K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DARE and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was InterWest Venture Management, opening a new position worth an estimated $40.9K. The largest seller was Founders Financial Securities, exiting entirely with an estimated $16K sold.
- 14 institutional investors held Dare Bioscience (DARE) as of Q4 2019, down from 16 in Q3 2019.
- Funds reported $725K of Dare Bioscience stock for Q4 2019, up 16% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q4 2019 and 5 closed out, a net change of -2 holders.
- The largest Dare Bioscience buyer in Q4 2019 was InterWest Venture Management, an estimated $40.9K added.
- The largest Dare Bioscience seller in Q4 2019 was Founders Financial Securities, an estimated $16K sold.
Based on aggregated 13F filings for Q4 2019.